Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/19 → 1/01/23 |
-
Leukotriene Signaling as a Target in alpha-Synucleinopathies
Strempfl, K. (First author), Unger, M., Flunkert, S., Trost, A. (Co-author), Reitsamer, H. (Co-author), Hutter-Paier, B. & Aigner, L. (Last author), 2022, In: Biomolecules. 12, 3, p. 346Research output: Contribution to journal › Review article › peer-review
12 Citations (Web of Science) -
CD4+ T cells contribute to neurodegeneration in Lewy body dementia
Gate, D., Tapp, E., Leventhal, O., Shahid, M., Nonninger, T. J., Yang, A. C., Strempfl, K. (Co-author), Unger, M. S. (Co-author), Fehlmann, T., Oh, H., Channappa, D., Henderson, V. W., Keller, A., Aigner, L. (Co-author), Galasko, D. R., Davis, M. M., Poston, K. L. & Wyss-Coray, T., 2021, In: SCIENCE . 374, 6569, p. 868-874Research output: Contribution to journal › Original Article › peer-review
168 Citations (Web of Science) -
The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.
Marschallinger, J. (First author), Altendorfer, B. (First author), Rockenstein, E., Holztrattner, M., Garnweidner-Raith, J., Pillichshammer, N., Leister, I. (Co-author), Hutter-Paier, B., Strempfl, K. (Co-author), Unger, M. S. (Co-author), Chishty, M., Felder, T. (Co-author), Johnson, M., Attems, J., Masliah, E. & Aigner, L. (Last author), 2020, In: NEUROTHERAPEUTICS. 17, 3, p. 1061-1074Research output: Contribution to journal › Original Article › peer-review
32 Citations (Web of Science)